Strand Life Sciences is an Indian biotechnology company based in Bengaluru, specializing in genomics, bioinformatics, and precision medicine. Founded in 2000, it operates as a subsidiary of Reliance Industries Limited after a 2021 acquisition. The company employs a diverse team of professionals, including scientists, engineers, and researchers, who work on various aspects of life sciences. Strand offers a range of services, including clinical diagnostics and genomic profiling, pharma and biomarker discovery, bioinformatics, and software development. Their clinical diagnostics utilize next-generation sequencing (NGS) and PCR testing for hereditary cancer risk and variant analysis. In addition, they provide data generation and analysis workflows for pharmaceutical companies, along with custom software solutions for life sciences. Their proprietary tools include StrandNGS for NGS data analysis and platforms like GeneSpring and MassProfiler Professional for omics data management. With over 24 years of experience, Strand Life Sciences focuses on innovation and quality, aiming to turn complex genomic data into actionable healthcare solutions for clients in the pharmaceutical and healthcare sectors.